Literature DB >> 5765289

Uric acid nephropathy: an experimental model.

B Stavric, W J Johnson, H C Grice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5765289     DOI： 10.3181/00379727-130-33593

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  8 in total

1.  Fortuitous discovery of urate nephrolithiasis in rats subjected to portacaval anastomosis.

Authors:  R Herz; V Sauter; J Bircher
Journal:  Experientia       Date:  1972-01-15

2.  Acute hyperuricemic nephropathy in rats. An electron microscopic study.

Authors:  J Waisman; L M Mwasi; R Bluestone; J R Klinenberg
Journal:  Am J Pathol       Date:  1975-11       Impact factor: 4.307

3.  A micropuncture study of the early phase of acute urate nephropathy.

Authors:  J D Conger; S A Falk; S J Guggenheim; T J Burke
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

4.  Effects of uric acid dysregulation on the kidney.

Authors:  Lashodya V Dissanayake; Denisha R Spires; Oleg Palygin; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-30

5.  Inhibition of adjuvant-induced arthritis in the hyperuricemic rat.

Authors:  A Lussier; R de Medicis; L Marquis; H Menard
Journal:  Agents Actions       Date:  1978-10

6.  Silkworms can be used as an animal model to screen and evaluate gouty therapeutic drugs.

Authors:  Xiaoli Zhang; Renyu Xue; Guangli Cao; Zhonghua Pan; Xiaojian Zheng; Chengliang Gong
Journal:  J Insect Sci       Date:  2012       Impact factor: 1.857

7.  Allopurinol reduces the lethality associated with acute renal failure induced by Crotalus durissus terrificus snake venom: comparison with probenecid.

Authors:  Rodrigo Frezzatti; Paulo Flavio Silveira
Journal:  PLoS Negl Trop Dis       Date:  2011-09-06

8.  Oral uricase eliminates blood uric acid in the hyperuricemic pig model.

Authors:  Paulina Szczurek; Nadia Mosiichuk; Jarosław Woliński; Tetiana Yatsenko; Danica Grujic; Liudmyla Lozinska; Marek Pieszka; Ewa Święch; Stefan Grzegorz Pierzynowski; Kateryna Goncharova
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.